A deletion in TYMS 3′ untranslated region has been associated with PMX treatment outcome in MM23, but studies in NSCLC gave inconsistent results, suggesting further studies are needed regarding the role of this polymorphism24, 25. This evidence concerns the gene TYMS and non-small cell lung carcinoma.